Signaling Pathways - Nrf2 - Hypoxia Inducible Factors (HIFs) - Ribosomes - Insulin and Insulin-like Receptors
清除全部
-
B6004 PX-478 2HClTarget: Hypoxia Inducible Factors (HIFs)Summary: HIF-1α抑制剂 -
B3576 Omaveloxolone (RTA-408)Target: Nrf2Summary: Nrf2激活剂 -
B1115 BAY 87-2243Target: Hypoxia Inducible Factors (HIFs)Summary: 有效的HIF-1选择性抑制剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A3335 Curcumin1 Citation中文名: 姜黄素Target: Histone Deacetylases (HDACs)|Nrf2|Histone Acetyltransferases (HATs)|TyrosinasesSummary: Tyrosinase（酪氨酸酶）抑制剂 -
A3221 Bardoxolone methyl中文名: 甲基巴多索隆Target: Nrf2Summary: IKK抑制剂，强效的抗氧化炎性反应调节剂。 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂